Bottom line
HRTS vs ETHSX: the short answer
HRTS (Tema Heart & Health ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both etfs.
HRTS is cheaper at 0.75% vs 1.18% — a difference of $43 a year per $10,000 invested.
Over one year, HRTS returned +23.6% vs −1.9% for ETHSX (reporting dates differ).
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
HRTS vs ETHSX side by side
| HRTS | ETHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Innovator | Morgan Stanley |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 1.18% |
| Annual cost per $10k | $75 | $118 |
| 10-yr cost on $10k (prospectus) | $1,168 | $1,911 |
| Max front load | None | 5.25% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +23.6% | −1.9% |
| 5-yr return (annualized) | — | +5.3% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +15.8% | +14.2% |
| Worst quarter | −12.4% | −12.1% |
| Net assets (fund) | $51.9M | $757.9M |
| Number of holdings | 45 | 42 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HRTS | ETHSX | Difference |
|---|---|---|---|
| 2024 | +3.6% | +3.5% | +0.1% |
Source: Fund prospectus bar charts
Holdings overlap
14 of HRTS's top 25 holdings also appear in ETHSX's top 25.
| Holding | HRTS | ETHSX |
|---|---|---|
| Eli Lilly & Co | 11.52% | 12.47% |
| UnitedHealth Group Inc | 5.24% | 5.49% |
| Novo Nordisk A/S | 5.24% | 1.71% |
| Merck & Co Inc | 4.27% | 5.08% |
| AstraZeneca PLC | 4.00% | 6.24% |
| Thermo Fisher Scientific Inc | 3.97% | 2.79% |
| Johnson & Johnson | 3.59% | 6.45% |
| Gilead Sciences Inc | 3.43% | 3.34% |
| Novartis AG | 3.38% | 1.65% |
| Vertex Pharmaceuticals Inc | 2.93% | 3.38% |
| Abbott Laboratories | 2.61% | 1.65% |
| AbbVie Inc | 2.40% | 6.46% |
| Bristol-Myers Squibb Co | 2.09% | 4.25% |
| Medtronic PLC | 1.88% | 1.80% |
Source: SEC Form N-PORT
HRTS top 10
- Eli Lilly & Co — 11.52%
- UnitedHealth Group Inc — 5.24%
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- Merck & Co Inc — 4.27%
- AstraZeneca PLC — 4.00%
- Thermo Fisher Scientific Inc — 3.97%
- Johnson & Johnson — 3.59%
- Gilead Sciences Inc — 3.43%
- Novartis AG — 3.38%
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
FAQ
What is the difference between HRTS and ETHSX?
Which is cheaper, HRTS or ETHSX?
Should I own both HRTS and ETHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.